Charbonneau v. Boehringer Ingelheim Pharmaceuticals, Inc. and Pfizer, Inc.

Achieved jury verdict for plaintiffs of $8,279,300, including $7.8 million in punitive damages, for failing to warn of risk of compulsive behaviors, including pathological gambling, from the Parkinson's drug Mirapex.

Achieved jury verdict for plaintiffs of $8,279,300, including $7.8 million in punitive damages, for failing to warn of risk of compulsive behaviors, including pathological gambling, from the Parkinson's drug Mirapex.
+ READ MORE - READ LESS
Past results are reported to provide the reader with an indication of the type of litigation we practice. They do not and should not be construed to create an expectation of result in any other case, as all cases are dependent upon their own unique fact situation and applicable law.
Disclaimer
Back to Top